Rostyslav Stoika
Rostyslav Stoika
Head of Department, Institute of Cell Biology, NAS of Ukraine; Professor of Department of Normal
Zweryfikowany adres z cellbiol.lviv.ua - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Expression of Smad proteins in human colorectal cancer
O Korchynskyi, M Landström, R Stoika, K Funa, CH Heldin, P ten Dijke, ...
International journal of cancer 82 (2), 197-202, 1999
1381999
Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles
RO Bilyy, T Shkandina, A Tomin, LE Muñoz, S Franz, V Antonyuk, YY Kit, ...
Journal of Biological Chemistry 287 (1), 496-503, 2012
1042012
Application of C60 fullerene-doxorubicin complex for tumor cell treatment in vitro and in vivo
RR Panchuk, SV Prylutska, VV Chumak, NR Skorokhyd, LV Lehka, ...
Journal of biomedical nanotechnology 11 (7), 1139-1152, 2015
952015
Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane
S Prylutska, R Bilyy, M Overchuk, A Bychko, K Andreichenko, R Stoika, ...
Journal of biomedical nanotechnology 8 (3), 522-527, 2012
892012
Mechanisms underlying the anticancer activities of the angucycline landomycin E
A Korynevska, P Heffeter, B Matselyukh, L Elbling, M Micksche, R Stoika, ...
Biochemical pharmacology 74 (12), 1713-1726, 2007
802007
Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells
V Kaminskyy, KW Lin, Y Filyak, R Stoika
Cell Biology International 32 (2), 271-277, 2008
732008
A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids
V Kaminskyy, O Kulachkovskyy, R Stoika
Toxicology letters 177 (3), 168-181, 2008
602008
C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance
S Prylutska, R Panchuk, G Gołuński, L Skivka, Y Prylutskyy, V Hurmach, ...
Nano Research 10 (2), 652-671, 2017
562017
Complex of C 60 fullerene with doxorubicin as a promising agent in antitumor therapy
SV Prylutska, LM Skivka, GV Didenko, YI Prylutskyy, MP Evstigneev, ...
Nanoscale research letters 10 (1), 1-7, 2015
562015
5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells
J Senkiv, N Finiuk, D Kaminskyy, D Havrylyuk, M Wojtyra, I Kril, A Gzella, ...
European journal of medicinal chemistry 117, 33-46, 2016
552016
Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects
A Philchenkov, V Kaminskyy, M Zavelevich, R Stoika
Toxicology in vitro 22 (2), 287-295, 2008
542008
Search for novel cell surface markers of apoptotic cells
R Bilyy, R Stoika
Autoimmunity 40 (4), 249-253, 2007
542007
Lectinocytochemical detection of apoptotic murine leukemia L1210 cells
RO Bilyy, RS Stoika
Cytometry Part A: The Journal of the International Society for Analytical …, 2003
522003
Correlation of the cytotoxic activity of four different alkaloids, from Chelidonium majus (greater celandine), with their DNA intercalating properties and ability to induce …
VO Kaminskyy, MD Lootsik, RS Stoika
Central European Journal of Biology 1 (1), 2-15, 2006
512006
Cytochemical study of role of α-d-mannose-and β-d-galactose-containing glycoproteins in apoptosis
RO Bilyy, VO Antonyuk, RS Stoika
Journal of molecular histology 35 (8-9), 829-838, 2004
502004
The use of oligoperoxide-coated magnetic nanoparticles to label stem cells
D Šponarová, D Horák, M Trchová, P Jendelová, V Herynek, N Mitina, ...
Journal of biomedical nanotechnology 7 (3), 384-394, 2011
492011
In vitro response of phagocytic cells to immunomodulating agents
R Stoika, N Kashchak, M Lutsik-Kordovsky, M Boyko, A Tsyrulnyk
Med Sci Monit 7 (4), 652-658, 2001
392001
Chemistry and biology of landomycins, an expanding family of polyketide natural products
B Ostash, A Korynevska, R Stoika, V Fedorenko
Mini reviews in medicinal chemistry 9 (9), 1040-1051, 2009
372009
Apoptosis and cancer
AA Filchenkov, RS Stoika
Kyiv, Morion, 1999
371999
Nanoformulation improves activity of the (pre) clinical anticancer ruthenium complex KP1019
P Heffeter, A Riabtseva, Y Senkiv, CR Kowol, W Körner, U Jungwith, ...
Journal of biomedical nanotechnology 10 (5), 877-884, 2014
362014
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20